This website uses cookies to enhance the user experience.
P

PALLA PHARMA NORWAY HOLDING AS919 610 581

Process industry
Limited company
Gruveveien 1 3770 KRAGERØ, Norge

PALLA PHARMA NORWAY HOLDING AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Chairman of the board
Years since formation
7 years
since Sep 22, 2017
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
18,496
1 share class
Total number of shareholders
66
8 companies, 58 persons
Belongs to group of

Financials

Annual total result 2023
-719,884
NOK
Total equity 2023
126,675,696
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Chairman-
Board Member
10.81 %
indirectly
Board Member-
Board Member
16.71 %
indirectly
Board Member
1.27 %
indirectly

Others

NameRoleShares
K
KPMG AS
Auditor-
V
VALUE KRAGERØ AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
27.36 %
indirectly
Board Member
16.71 %
indirectly
Board Member
10.81 %
indirectly
-
7.48 %
indirectly
-
6.01 %
indirectly
-
5.41 %
indirectly
-
1.68 %
directly
Board Member
1.27 %
indirectly
-
1.27 %
indirectly
Last update: Sep 18, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
M
MA-INVEST AS
Ordinary shares
6,172
33.37 %
K
KILEN EIENDOM AS
Ordinary shares
3,090
16.71 %
L
LMS HOLDCO AS
Ordinary shares
2,000
10.81 %
Ordinary shares
1,540
8.33 %
M
MARITOPPEN INVEST AS
Ordinary shares
1,540
8.33 %
H
HOLGER INVEST I AS
Ordinary shares
1,000
5.41 %
P
PALLA PHARMA ANSATTFORENING
Ordinary shares
987
5.34 %
H
HJALLUM HOLDING AS
Ordinary shares
470
2.54 %
Ordinary shares
310
1.68 %
Ordinary shares
100
0.54 %
Ordinary shares
95
0.51 %
Ordinary shares
93
0.5 %
Ordinary shares
70
0.38 %
Ordinary shares
62
0.34 %
Ordinary shares
62
0.34 %
P
PHARMCONSULT AS
Ordinary shares
50
0.27 %
Ordinary shares
50
0.27 %
Ordinary shares
32
0.17 %
Ordinary shares
31
0.17 %
Ordinary shares
31
0.17 %
Ordinary shares
31
0.17 %
Ordinary shares
31
0.17 %
Ordinary shares
31
0.17 %
Ordinary shares
30
0.16 %
Ordinary shares
23
0.12 %
Ordinary shares
20
0.11 %
Ordinary shares
20
0.11 %
Ordinary shares
20
0.11 %
Ordinary shares
19
0.1 %
Ordinary shares
19
0.1 %
Ordinary shares
17
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
16
0.09 %
Ordinary shares
15
0.08 %
Ordinary shares
15
0.08 %
Ordinary shares
15
0.08 %
Ordinary shares
15
0.08 %
Ordinary shares
15
0.08 %
Ordinary shares
13
0.07 %
Ordinary shares
13
0.07 %
Ordinary shares
10
0.05 %
Ordinary shares
10
0.05 %
Ordinary shares
10
0.05 %
Ordinary shares
10
0.05 %
Ordinary shares
7
0.04 %
Ordinary shares
7
0.04 %
Ordinary shares
6
0.03 %
Ordinary shares
6
0.03 %
Ordinary shares
5
0.03 %
Ordinary shares
3
0.02 %
Ordinary shares
3
0.02 %

Shares owned by the PALLA PHARMA NORWAY HOLDING AS

NameShare classNumber of sharesShare
P
PALLA PHARMA NORWAY AS
Ordinary shares
30,000
100 %
P
PALLA PHARMA EIENDOM AS
Ordinary shares
3,000
100 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-719,884
76,461
-5,562,503
Total assets
147,416,483
136,120,937
99,792,078
Total liabilities
20,740,787
8,725,358
172,253,208
Total equity
126,675,696
127,395,580
-72,461,130

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
361,152
258,100
0
Operating result
-361,152
-258,100
0
Financial income/costs
-358,732
334,561
-5,562,503
Profit before tax
-719,884
76,461
-5,562,503
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-719,884
76,461
-5,562,503

Balance overview

Year202320222021
Total fixed assets
141,279,273
134,679,273
82,000,000
Total current assets
6,137,210
1,441,664
17,792,078
Total assets
147,416,483
136,120,937
99,792,078
Short term debt
20,740,787
8,725,358
66,253,208
Long term debt
0
0
106,000,000
Total liabilities
20,740,787
8,725,358
172,253,208
Contributed capital
126,675,696
127,395,580
33,866,246
Retained earnings
0
0
-106,327,376
Total equity
126,675,696
127,395,580
-72,461,130
Total equity and liabilities
147,416,483
136,120,937
99,792,078

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations